(Q80362811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

ChEBI release 2020-05-28

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Nektarios Aligiannis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

E Kassi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Z Papoutsi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M Manoussakis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

P Moutsatsou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

15 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

493-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-007-0193-1

30 December 2019

exact match

0 references

cites work

The biology of hormone refractory prostate cancer. Why does it develop?

1 reference

12 December 2020

The effect of interleukin-6 on the proliferation of prostate cancer cells in vitro and the modulation of this procedure

1 reference

12 December 2020

Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro

1 reference

12 December 2020

Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells.

1 reference

12 December 2020

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

1 reference

12 December 2020

Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells

1 reference

12 December 2020

Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter

1 reference

12 December 2020

Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells

1 reference

12 December 2020

Collocation of androgen receptor gene mutations in prostate cancer

1 reference

12 December 2020

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

12 December 2020

Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer

1 reference

12 December 2020

Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells

1 reference

12 December 2020

A combination therapy of dexamethasone and somatostatin analog reintroduces objective clinical responses to LHRH analog in androgen ablation-refractory prostate cancer patients

1 reference

12 December 2020

Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview

1 reference

12 December 2020

Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

1 reference

12 December 2020

Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells

1 reference

12 December 2020

Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer

1 reference

12 December 2020

Prostate cancer: epidemiology, screening, and biomarkers

1 reference

12 December 2020

Growth inhibition of androgen-insensitive human prostate carcinoma cells by a 19-norsteroid derivative agent, mifepristone

1 reference

12 December 2020

Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases

1 reference

12 December 2020

Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview

1 reference

12 December 2020

Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.

1 reference

12 December 2020

Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1

1 reference

12 December 2020

Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells

1 reference

12 December 2020

Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target

1 reference

12 December 2020

A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer

1 reference

12 December 2020

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.

1 reference

12 December 2020

Antiandrogen Effects of Mifepristone on Coactivator and Corepressor Interactions with the Androgen Receptor

1 reference

12 December 2020

Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture

1 reference

12 December 2020

LNCaP model of human prostatic carcinoma.

1 reference

12 December 2020

Prostate specific antigen levels and clinical response to low dose dexamethasone for hormone-refractory metastatic prostate carcinoma

1 reference

12 December 2020

New approaches in hormone refractory prostate cancer

1 reference

12 December 2020

Low doses of oral dexamethasone for hormone-refractory prostate carcinoma

1 reference

12 December 2020

Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.

1 reference

12 December 2020

10.1007/S00432-007-0193-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516089%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference